Trials / Conditions / Attention Deficit Hyperactivity Disorder Combined
Attention Deficit Hyperactivity Disorder Combined
5 registered clinical trials studyying Attention Deficit Hyperactivity Disorder Combined — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301 NCT05286762 | Cingulate Therapeutics | Phase 3 |
| Suspended | Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301 NCT05924594 | Cingulate Therapeutics | Phase 3 |
| Completed | Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301. NCT05631626 | Cingulate Therapeutics | Phase 3 |
| Recruiting | Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder NCT04421248 | Donald Gilbert, MD, MS, FAAN, FAAP | Phase 4 |
| Completed | Evaluating the Feasibility of FAM-SOTC Intervention for Families of Adolescents With ADHD: Pilot Study NCT04378517 | University of Iceland | N/A |